Results
Samsung Biologics Co. Ltd.
Samsung Biologics Co. Ltd.
12/03/2025 | Press release | Distributed by Public on 12/04/2025 00:58
Embedding ExellenS™ into engineering expertise to deliver standardized and reliable biomanufacturing facilities
UPDATE |December 4, 2025
Embedding ExellenS™ into engineering expertise to deliver standardized and reliable biomanufacturing facilities
- COPY
While many CDMOs approach each client project as a standalone endeavor, often optimizing individual plants on a case-by-case basis, Samsung Biologics has adopted a fundamentally different model.
ExellenS™ ensures that each successive plant not only replicates but also enhances the performance and dependability of its predecessors. By continuously improving and standardizing every stage of engineering, procurement, construction, and validation (EPCV), Samsung Biologics has created a repeatable, reliable framework for facility performance.
While many CDMOs approach each client project as a standalone endeavor, often optimizing individual plants on a case-by-case basis, Samsung Biologics has adopted a fundamentally different model.
ExellenS™ ensures that each successive plant not only replicates but also enhances the performance and dependability of its predecessors. By continuously improving and standardizing every stage of engineering, procurement, construction, and validation (EPCV), Samsung Biologics has created a repeatable, reliable framework for facility performance.
Attached
- Embedding ExellenS™ into engineering expertise to deliver standardized and reliable biomanufacturing facilities
Related Content
Samsung Biologics Co. Ltd. published this content on December 03, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 04, 2025 at 06:58 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]